<DOC>
	<DOCNO>NCT01871662</DOCNO>
	<brief_summary>The purpose study explore whether silibinin plus ribavirin with/without peg-interferon effective peg-interferon plus ribavirin base standard care ( SoC ) treatment patient infect hepatitis C virus genotype 4 .</brief_summary>
	<brief_title>Randomized Study Assessment Silibinin ( Legalon® SIL ) Treatment naïve Genotype 4 Patients With Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Silybin</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<criteria>Patient must willing give write informed consent Male female patient ; age 21 45 year inclusive Chronic hepatitis C infection genotype 4 confirm genotypic test screen within 6 month screen period Patients eligible treated RBV PegIFN per instruction present prescribe information document No history prior interferon therapy ( treatment naïve ) Detectable HCVRNA level Normal BUN creatinine Ability communicate , participate , comply requirement entire study Liver transplant patient CoInfection HIV and/or HBV ALT &gt; 10fold upper limit normal i.e . &gt; 400 U/L Evidence hepatocellular carcinoma ( HCC ) Fibroscan® screen score ≥ 14.5 kPa Evidence liver disease due cause chronic HCV infection Evidence poorly control diabetes ( define HbA1c &gt; 8 % ) History alcohol drug abuse within last 12 month History clinical evidence liver decompensation , e.g . presence ascites encephalopathy , bleed esophageal varix Serum albumin level &lt; 3.2 g/dL INR &gt; 1.3 N Total Bilirubin level &gt; 2.0 mg/dL unless explain Gilbert 's disease Platelet Count &lt; 100,000 µL Absolute Neutrophil count &lt; 1500 µL ( mm3 ) Active suspect nonhepatic malignancy history malignancy within last 5 year Body Mass Index &lt; 16 &gt; 35 kg/m2 Females childbearing potential : Pregnancy ( i.e . positive urine pregnancy test screening ) lactation Failure agree practice adequate contraception method ( e.g . oral contraceptive , intrauterine device ( IUD ) , transdermal contraceptive patch ) Male patient vasectomize , agree abstain intercourse use condom</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>HCV</keyword>
	<keyword>Hepatitis C</keyword>
</DOC>